These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6278021)

  • 21. A monoclonal antibody-inhibiting FMLP-induced chemotaxis of human neutrophils.
    Cotter TG; Keeling PJ; Henson PM
    J Immunol; 1981 Dec; 127(6):2241-5. PubMed ID: 7053244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of a specific receptor for formyl-methionyl-leucyl-phenylalanine on th pulmonary alveolar macrophage and its relationship to chemotaxis and superoxide production.
    Spilberg I; Mehta J; Daughaday C; Simchowitz L
    J Lab Clin Med; 1981 May; 97(5):602-9. PubMed ID: 6260878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo effects of treatment by platelet-activating factor on N-formyl-met-leu-phe-mediated responses of polymorphonuclear leucocytes.
    Ingraham LM; Lafuze JE; Boxer LA; Baehner RL
    Br J Haematol; 1987 Jun; 66(2):219-25. PubMed ID: 3038160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenosine inhibits platelet-activating factor, but not tumour necrosis factor-alpha-induced priming of human neutrophils.
    Stewart AG; Harris T
    Immunology; 1993 Jan; 78(1):152-8. PubMed ID: 8382188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukocyte inhibitory factor (LIF) potentiates human macrophage aggregation and activation responses to calcium ionophore A23187 and directly induces leukotriene B4 and thromboxane A2 release.
    Conti P; Barbacane RC; Reale M; Panara MR; Placido FC; Mier JW; Castracane JM; Dempsey RA
    Biotechnol Ther; 1993; 4(3-4):239-52. PubMed ID: 8292972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of chemotactic factor-induced neutrophil responsiveness by arachidonic acid.
    Naccache PH; Molski TF; Volpi M; Mackin WM; Becker EL; Sha'afi RI
    J Cell Physiol; 1983 Jun; 115(3):243-8. PubMed ID: 6406520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
    Radhika V; Thennarasu S; Naik NR; Kumar A; Advani SH; Bhisey AN
    Am J Hematol; 1996 Jul; 52(3):155-64. PubMed ID: 8756080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Response of adenosine cyclic 3',5'-monophosphate level in rabbit neutrophils to the chemotactic peptide formyl-methionyl-leucyl-phenylalanine.
    Jackowski S; Sha'afi RI
    Mol Pharmacol; 1979 Sep; 16(2):473-81. PubMed ID: 229400
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of terfenadine on human eosinophil and neutrophil chemotactic response and generation of superoxide.
    Eda R; Townley RG; Hopp RJ
    Ann Allergy; 1994 Aug; 73(2):154-60. PubMed ID: 8067599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the chemotactic factor formyl methionyl- leucyl-phenylalanine and cytochalasin B on the cellular levels of calcium in rabbit neutrophils.
    Petroski RJ; Naccache PH; Becker EL; Sha'afi RI
    FEBS Lett; 1979 Apr; 100(1):161-5. PubMed ID: 437100
    [No Abstract]   [Full Text] [Related]  

  • 31. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
    Shaw JO; Pinckard RN; Ferrigni KS; McManus LM; Hanahan DJ
    J Immunol; 1981 Sep; 127(3):1250-5. PubMed ID: 6267133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of human polymorphonuclear leukocyte superoxide release by cellular responses to chemotactic peptides.
    English D; Roloff JS; Lukens JN
    J Immunol; 1981 Jan; 126(1):165-71. PubMed ID: 6256437
    [No Abstract]   [Full Text] [Related]  

  • 33. Biochemical, metabolic and morphological characteristics of human neutrophil activation with pepstatin A.
    Smith RJ; Bowman BJ; Iden SS; Kolaja GJ; Wiser SK
    Immunology; 1983 Jun; 49(2):367-77. PubMed ID: 6303951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonists of the formylated peptide chemoattractants: structure-activity comparisons with formyl-methionyl-leucyl-phenylalanine-OH.
    Freer RJ; Day AR; Muthukumaraswamy N; Showell HJ; Becker EL
    Kroc Found Ser; 1981; 14():161-8. PubMed ID: 6947071
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanism of dexamethasone inhibition of chemotactic factor induced granulocyte aggregation.
    Oseas RS; Allen J; Yang HH; Baehner RL; Boxer LA
    Blood; 1982 Feb; 59(2):265-9. PubMed ID: 7055639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil aggregation: effect of the time and sequence of addition of calcium, magnesium and chemotactic factor.
    O'Flaherty JT; Showell HS; Becker EL; Ward PA
    J Reticuloendothel Soc; 1979 Jan; 25(1):29-38. PubMed ID: 430469
    [No Abstract]   [Full Text] [Related]  

  • 37. The onset of polymorphonuclear leucocyte membrane-stimulated metabolic activity.
    Williams AJ; Cole PJ
    Immunology; 1981 Aug; 43(4):733-9. PubMed ID: 7275176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor.
    Filep J; Földes-Filep E
    Life Sci; 1989; 44(8):517-24. PubMed ID: 2538700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of polymorphonuclear leukocyte function by cetiedil.
    Wolach JB; Coates TD; Tzeng DY; Baehner RL; Boxer LA
    Blood; 1983 Aug; 62(2):274-9. PubMed ID: 6307427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sequential release of granule constitutents from human neutrophils.
    Bentwood BJ; Henson PM
    J Immunol; 1980 Feb; 124(2):855-62. PubMed ID: 6153206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.